• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • AI Executive AssistantNEW
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • AI Executive AssistantNEW
  • Settings
  • RSS Feeds
PublishGo to AppAI Helper
    Quantisnow Logo

    © 2025 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI employees for your businessNEW
    Legal
    Terms of usePrivacy policyCookie policy

    Baxter Declares Quarterly Dividend

    11/11/24 6:45:00 PM ET
    $BAX
    $CG
    Medical/Dental Instruments
    Health Care
    Investment Managers
    Finance
    Get the next $BAX alert in real time by email

    Baxter International Inc. (NYSE:BAX), a global medtech leader, today announced that its Board of Directors has declared a quarterly cash dividend of $0.17 per share of common stock. The dividend is payable on Jan. 2, 2025, to stockholders of record as of Nov. 29, 2024. The indicated annual dividend rate is $0.68 per share of common stock.

    This dividend represents the new quarterly dividend rate for Baxter in anticipation of the divestiture of its Kidney Care business segment to Carlyle (NASDAQ:CG), which is expected to close in late 2024 or early 2025, subject to receipt of customary regulatory approvals and satisfaction of other closing conditions. Over its 93-year history, Baxter has consistently paid a dividend to its stockholders and maintained a disciplined approach to capital allocation that balances reinvestment in the business with returning significant value to the company's investors through dividends and share repurchases.

    "This quarterly dividend targets a payout ratio of approximately 25% of adjusted net income over time and places Baxter in line with its peer set," said Joel Grade, Baxter's executive vice president and chief financial officer. "Post the sale of the Kidney Care segment, Baxter will emerge with enhanced strategic clarity, committed to a disciplined capital allocation philosophy that is focused on driving value for all stakeholders, which includes returning value to our stockholders through regular dividends."

    About Baxter

    Every day, millions of patients, caregivers and healthcare providers rely on Baxter's leading portfolio of diagnostic, critical care, kidney care, nutrition, hospital and surgical products used across patient homes, hospitals, physician offices and other sites of care. For more than 90 years, we've been operating at the critical intersection where innovations that save and sustain lives meet the healthcare providers who make it happen. With products, digital health solutions and therapies available in more than 100 countries, Baxter's employees worldwide are now building upon the company's rich heritage of medical breakthroughs to advance the next generation of transformative healthcare innovations. To learn more, visit www.baxter.com and follow us on X, LinkedIn and Facebook.

    This release includes forward-looking statements concerning the company's capital allocation, which currently includes the issuance of quarterly dividends, and the pending sale of the Kidney Care business (including the expected timeframe for completing the proposed transaction). These forward-looking statements are based on assumptions about many factors (including Baxter's ability to achieve its short- and long-term financial goals, including after giving effect to the pending Kidney Care sale), and it is possible that Baxter's annual dividend payout rate may differ, possibly materially, from the anticipated annual indicative dividend described herein or may be suspended for a period of time. For information about some of the risks and important factors that could affect Baxter's future results, financial condition and liquidity, see Baxter's most recent filings on Forms 10-K and 10-Q and other SEC filings, all of which are available on Baxter's website. Baxter does not undertake to update its forward-looking statements unless otherwise required by the federal securities laws.

    Baxter is a registered trademark of Baxter International Inc.

    View source version on businesswire.com: https://www.businesswire.com/news/home/20241111890466/en/

    Get the next $BAX alert in real time by email

    Crush Q3 2025 with the Best AI Executive Assistant

    Stay ahead of the competition with Tailforce.ai - your AI-powered business intelligence partner.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Tailforce.ai

    Recent Analyst Ratings for
    $BAX
    $CG

    CompanyDatePrice TargetRatingAnalyst
    The Carlyle Group Inc.
    $CG
    7/10/2025$65.00Neutral → Buy
    Citigroup
    The Carlyle Group Inc.
    $CG
    5/14/2025$56.00Hold → Buy
    TD Cowen
    The Carlyle Group Inc.
    $CG
    3/19/2025Outperform → Perform
    Oppenheimer
    Baxter International Inc.
    $BAX
    2/26/2025$42.00Buy
    Goldman
    Baxter International Inc.
    $BAX
    2/24/2025Hold → Buy
    Argus
    Baxter International Inc.
    $BAX
    2/20/2025$39.00Overweight
    Barclays
    The Carlyle Group Inc.
    $CG
    1/3/2025$60.00Peer Perform → Outperform
    Wolfe Research
    The Carlyle Group Inc.
    $CG
    9/12/2024$42.00Equal Weight
    Wells Fargo
    More analyst ratings

    $BAX
    $CG
    SEC Filings

    See more
    • Baxter International Inc. filed SEC Form 8-K: Leadership Update, Regulation FD Disclosure

      8-K - BAXTER INTERNATIONAL INC (0000010456) (Filer)

      7/7/25 8:51:26 AM ET
      $BAX
      Medical/Dental Instruments
      Health Care
    • Baxter International Inc. filed SEC Form 8-K: Entry into a Material Definitive Agreement, Termination of a Material Definitive Agreement, Creation of a Direct Financial Obligation

      8-K - BAXTER INTERNATIONAL INC (0000010456) (Filer)

      6/12/25 8:48:57 AM ET
      $BAX
      Medical/Dental Instruments
      Health Care
    • The Carlyle Group Inc. filed SEC Form 8-K: Entry into a Material Definitive Agreement, Creation of a Direct Financial Obligation, Submission of Matters to a Vote of Security Holders

      8-K - Carlyle Group Inc. (0001527166) (Filer)

      5/30/25 5:19:46 PM ET
      $CG
      Investment Managers
      Finance

    $BAX
    $CG
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    See more
    • SEC Form 4 filed by Large owner Carlyle Group Inc.

      4 - Carlyle Group Inc. (0001527166) (Reporting)

      7/2/25 6:00:04 PM ET
      $CG
      Investment Managers
      Finance
    • EVP and General Counsel Rosenbloom David S. covered exercise/tax liability with 16,548 shares, decreasing direct ownership by 13% to 106,327 units (SEC Form 4)

      4 - BAXTER INTERNATIONAL INC (0000010456) (Issuer)

      6/4/25 4:06:25 PM ET
      $BAX
      Medical/Dental Instruments
      Health Care
    • Large owner Carlyle Group Inc. sold $100,225,698 worth of shares (3,671,271 units at $27.30) (SEC Form 4)

      4 - Carlyle Group Inc. (0001527166) (Reporting)

      6/2/25 4:30:39 PM ET
      $CG
      Investment Managers
      Finance

    $BAX
    $CG
    Press Releases

    Fastest customizable press release news feed in the world

    See more
    • Carlyle Credit Income Fund Schedules Third Quarter Financial Results and Investor Conference Call

      NEW YORK, July 23, 2025 (GLOBE NEWSWIRE) -- Carlyle Credit Income Fund ("we," "us," "our," "CCIF" or the "Fund") (NYSE:CCIF) announced today that it will release financial results after market close on Tuesday, August 19, 2025, for its third quarter of 2025. CCIF will host a conference call at 10:00 a.m. EST on Wednesday, August 20, 2025, to discuss the results. The conference call will be available via public webcast via a link on Carlyle Credit Income Fund's website at www.carlylecreditincomefund.com and will also be available on the website soon after the call's completion. About Carlyle Credit Income Fund Carlyle Credit Income Fund (NYSE:CCIF) is an externally managed closed-end fun

      7/23/25 4:00:00 PM ET
      $CCIF
      $CG
      Finance/Investors Services
      Finance
      Investment Managers
    • Adastra Acquired by Global Investment Firm Carlyle

      Adastra Group SE ("Adastra"), a leading global IT consultancy and services provider specializing in AI, data and cloud transformations today announced that Global investment firm Carlyle (NASDAQ:CG) has agreed to acquire a majority stake in the Group. Completion of the acquisition is subject to standard regulatory approvals in several jurisdictions. Founded in 2000 with headquarters in Prague, Czech Republic and Toronto, Canada, Adastra supports its customers throughout their AI, data, and cloud journey by defining data and AI-driven strategies and implementing transformative solutions to drive measurable business outcomes. It brings deep expertise in the financial services, automotive, m

      7/22/25 10:30:00 AM ET
      $CG
      Investment Managers
      Finance
    • Acentra Health Names Marnie Keogh as Senior Vice President of Marketing

      MCLEAN, Va., July 21, 2025 (GLOBE NEWSWIRE) -- Acentra Health, a technology and health solutions and services company dedicated to accelerating better outcomes for its government and commercial healthcare clients and the populations they serve, announced today that Marnie Keogh has joined the company as Senior Vice President of Marketing. In this role, Keogh will lead the company's integrated marketing strategy, driving initiatives across brand development, digital marketing, thought leadership, and go-to-market campaigns. "Marnie brings a distinguished career in healthcare marketing and communications, with a proven ability to drive brand transformation, operational excellence, and digit

      7/21/25 9:47:00 AM ET
      $CG
      Investment Managers
      Finance

    $BAX
    $CG
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    See more
    • Carlyle Group upgraded by Citigroup with a new price target

      Citigroup upgraded Carlyle Group from Neutral to Buy and set a new price target of $65.00

      7/10/25 8:23:02 AM ET
      $CG
      Investment Managers
      Finance
    • Carlyle Group upgraded by TD Cowen with a new price target

      TD Cowen upgraded Carlyle Group from Hold to Buy and set a new price target of $56.00

      5/14/25 8:48:54 AM ET
      $CG
      Investment Managers
      Finance
    • Carlyle Group downgraded by Oppenheimer

      Oppenheimer downgraded Carlyle Group from Outperform to Perform

      3/19/25 8:14:15 AM ET
      $CG
      Investment Managers
      Finance

    $BAX
    $CG
    FDA approvals

    Live FDA approvals issued by the Food and Drug Administration and FDA breaking news

    See more
    • October 18, 2024 - FDA Roundup: October 18, 2024

      For Immediate Release: October 18, 2024 Today, the U.S. Food and Drug Administration is providing an at-a-glance summary of news from around the agency:  This week, FDA continues ongoing efforts to increase access and supply of IV and peritoneal dialysis (PD) fluids following Hurricane Helene-related damage to Baxter International Inc.’s facility in Marion, North Carolina. Specifically, FDA acted quickly to c

      10/18/24 4:16:25 PM ET
      $NVCR
      $BAX
      Medical/Dental Instruments
      Health Care

    $BAX
    $CG
    Leadership Updates

    Live Leadership Updates

    See more
    • Acentra Health Names Marnie Keogh as Senior Vice President of Marketing

      MCLEAN, Va., July 21, 2025 (GLOBE NEWSWIRE) -- Acentra Health, a technology and health solutions and services company dedicated to accelerating better outcomes for its government and commercial healthcare clients and the populations they serve, announced today that Marnie Keogh has joined the company as Senior Vice President of Marketing. In this role, Keogh will lead the company's integrated marketing strategy, driving initiatives across brand development, digital marketing, thought leadership, and go-to-market campaigns. "Marnie brings a distinguished career in healthcare marketing and communications, with a proven ability to drive brand transformation, operational excellence, and digit

      7/21/25 9:47:00 AM ET
      $CG
      Investment Managers
      Finance
    • SS&C Technologies to Acquire Calastone

      SS&C Technologies Holdings, Inc. (NASDAQ:SSNC) today announced a definitive agreement to acquire Calastone, the largest global funds network and leading provider of technology solutions to the wealth and asset management industries, from global investment firm Carlyle. The purchase price is approximately £766 million (approximately US $1.03 billion), subject to certain adjustments. Headquartered in London, Calastone operates the largest global funds network, connecting more than 4,500 of the world's leading financial organizations across 57 markets. The acquisition is expected to close in Q4 2025, subject to regulatory approvals. SS&C expects the acquisition to be accretive within 12 mont

      7/21/25 4:00:00 AM ET
      $CG
      $SSNC
      Investment Managers
      Finance
      Computer Software: Prepackaged Software
      Technology
    • Baxter Appoints Andrew Hider Chief Executive Officer

      Baxter International Inc. (NYSE:BAX), a global medtech leader, today announced the appointment of Andrew Hider as president and chief executive officer (CEO), and a member of its board of directors. Mr. Hider will assume his responsibilities at Baxter no later than Sept. 3, 2025, or an earlier date pending completion of his current employment commitments. Brent Shafer, who has served as chair and interim CEO since February 2025, will then transition to independent chair of the Baxter Board. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250706840140/en/Andrew Hider Appointed Baxter's Next CEO Since 2017, Mr. Hider has served as

      7/7/25 8:35:00 AM ET
      $ATS
      $BAX
      Industrial Machinery/Components
      Industrials
      Medical/Dental Instruments
      Health Care

    $BAX
    $CG
    Financials

    Live finance-specific insights

    See more
    • Carlyle Credit Income Fund Schedules Third Quarter Financial Results and Investor Conference Call

      NEW YORK, July 23, 2025 (GLOBE NEWSWIRE) -- Carlyle Credit Income Fund ("we," "us," "our," "CCIF" or the "Fund") (NYSE:CCIF) announced today that it will release financial results after market close on Tuesday, August 19, 2025, for its third quarter of 2025. CCIF will host a conference call at 10:00 a.m. EST on Wednesday, August 20, 2025, to discuss the results. The conference call will be available via public webcast via a link on Carlyle Credit Income Fund's website at www.carlylecreditincomefund.com and will also be available on the website soon after the call's completion. About Carlyle Credit Income Fund Carlyle Credit Income Fund (NYSE:CCIF) is an externally managed closed-end fun

      7/23/25 4:00:00 PM ET
      $CCIF
      $CG
      Finance/Investors Services
      Finance
      Investment Managers
    • Baxter to Host Second-Quarter 2025 Financial Results Conference Call for Investors

      Baxter International Inc. (NYSE:BAX), a global medtech leader, will host a conference call to discuss its second-quarter 2025 financial results on Thursday, July 31, 2025 at 7:30 a.m. Central Time. To participate in this conference call please follow this link https://registrations.events/direct/Q4I156238 to pre-register for the call and receive the call information. This call is also being webcast and can be accessed through Baxter's website at www.baxter.com. The conference call will be recorded by Baxter and is copyrighted material. It cannot be recorded or rebroadcast without Baxter's permission. About Baxter At Baxter, we are everywhere healthcare happens – and everywhere it is g

      7/17/25 4:15:00 PM ET
      $BAX
      Medical/Dental Instruments
      Health Care
    • Carlyle Secured Lending, Inc. Schedules Earnings Release and Quarterly Earnings Call to Discuss its Financial Results for the Second Quarter Ended June 30, 2025

      NEW YORK, July 15, 2025 (GLOBE NEWSWIRE) -- Carlyle Secured Lending, Inc. ("Carlyle Secured Lending") (NASDAQ:CGBD) will host a conference call at 11:00 a.m. EST on Wednesday, August 6, 2025 to announce its financial results for the second quarter ended June 30, 2025. The Company will report its quarterly financial results on Tuesday, August 5, 2025. The conference call will be available via public webcast via a link on Carlyle Secured Lending's website at carlylesecuredlending.com and will also be available on the website soon after the call's completion. About Carlyle Secured Lending, Inc.     Carlyle Secured Lending, Inc. is a publicly traded (NASDAQ:CGBD) business development compan

      7/15/25 4:15:00 PM ET
      $CG
      $CGBD
      Investment Managers
      Finance
      Finance: Consumer Services

    $BAX
    $CG
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    See more
    • Amendment: SEC Form SC 13D/A filed by The Carlyle Group Inc.

      SC 13D/A - Carlyle Group Inc. (0001527166) (Subject)

      11/15/24 5:22:29 PM ET
      $CG
      Investment Managers
      Finance
    • Amendment: SEC Form SC 13G/A filed by Baxter International Inc.

      SC 13G/A - BAXTER INTERNATIONAL INC (0000010456) (Subject)

      11/13/24 1:08:27 PM ET
      $BAX
      Medical/Dental Instruments
      Health Care
    • Amendment: SEC Form SC 13D/A filed by The Carlyle Group Inc.

      SC 13D/A - Carlyle Group Inc. (0001527166) (Filed by)

      10/21/24 4:31:27 PM ET
      $CG
      Investment Managers
      Finance